DJI46,558.47-0.26%
GDAXI23,447.29-0.60%
GSPC6,632.19-0.61%
HSI25,465.60-0.98%
IXIC22,105.36-0.93%
N22553,819.61-1.16%
AAPL250.12-2.21%
AMZN207.67-0.89%
CL98.71+3.11%
EURUSD1.1423-0.82%
GBPUSD1.3223-0.93%
GC5,061.70-1.25%
GOOG301.46-0.58%
JPM283.44+0.19%
META613.71-3.83%
MSFT395.55-1.58%
NVDA180.25-1.59%
TSLA391.20-0.96%
DJI46,558.47-0.26%
GDAXI23,447.29-0.60%
GSPC6,632.19-0.61%
HSI25,465.60-0.98%
IXIC22,105.36-0.93%
N22553,819.61-1.16%
AAPL250.12-2.21%
AMZN207.67-0.89%
CL98.71+3.11%
EURUSD1.1423-0.82%
GBPUSD1.3223-0.93%
GC5,061.70-1.25%
GOOG301.46-0.58%
JPM283.44+0.19%
META613.71-3.83%
MSFT395.55-1.58%
NVDA180.25-1.59%
TSLA391.20-0.96%
DJI46,558.47-0.26%
GDAXI23,447.29-0.60%
GSPC6,632.19-0.61%
HSI25,465.60-0.98%
IXIC22,105.36-0.93%
N22553,819.61-1.16%
AAPL250.12-2.21%
AMZN207.67-0.89%
CL98.71+3.11%
EURUSD1.1423-0.82%
GBPUSD1.3223-0.93%
GC5,061.70-1.25%
GOOG301.46-0.58%
JPM283.44+0.19%
META613.71-3.83%
MSFT395.55-1.58%
NVDA180.25-1.59%
TSLA391.20-0.96%
LIVE
ESP Expansion ES

Morgan Stanley da marcha atrás en su apuesta por Grifols

La empresa del Ibex deja de ser una de las apuestas de Morgan Stanley. La firma estadounidense enumera tres factores que pueden lastrar sus ingresos, y su cotización, y limita su recomendación a 'neutral'. Leer

Mar 10, 2026 &03491010202631; 07:49 UTC e00-expansion.uecdn.es
Read original on e00-expansion.uecdn.es ↗
Negative for markets
Sentiment score: -65/100
Moderate impact Short-term (days)
WHAT THIS MEANS
Morgan Stanley has downgraded its stance on Grifols, removing it from its core investment thesis due to three identified headwinds that could pressure revenues and stock performance. The firm has shifted its recommendation to 'neutral', signaling reduced conviction in the Spanish pharmaceutical company's near-term prospects.
AI CONFIDENCE
85% Very high
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
GRF.MC
GRF.MCStock
Expected to decline
Morgan Stanley downgrade from buy to neutral with identified revenue headwinds
FTSE MIB (Italy)
FTSEMIB.MIIndex
High volatility expected
Grifols is an Ibex constituent; downgrade may create minor negative pressure on index
PRICE HISTORY
Loading chart...
SUGGESTED ACTION
Consider reducing long positions in Grifols or avoiding new entries until the three identified headwinds are clarified and addressed by management. Monitor for further analyst downgrades that could accelerate the decline.
KEY SIGNALS
Major analyst downgrade from bullish to neutralRemoval from Morgan Stanley's core investment thesisMultiple identified revenue headwindsPotential stock price pressure expected
SECTORS INVOLVED
HealthcarePharmaceuticalsBiotechnology
Analysis generated on Mar 11, 2026 at 04:00 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Expansion. Always conduct your own research and consult a qualified financial advisor before making investment decisions.